Arch Pharmalabs Limited Unlisted Share
₹85▲0.00%(0.00)
About the company
Arch Pharmalabs Limited is an Indian pharmaceutical company engaged in the manufacturing and supply of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company serves both innovator and generic pharmaceutical manufacturers across domestic and international markets, including several regulated markets, with a focus on quality, compliance, and reliable manufacturing.
Its business is organized into product and service segments, offering a diverse portfolio of APIs and intermediates used in the production of medicines across multiple therapeutic categories. Backed by advanced manufacturing capabilities and a strong emphasis on regulatory standards, Arch Pharmalabs continues to strengthen its presence in the global pharmaceutical industry through innovation, quality, and long-term customer partnerships.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | 99.3 |
| 52 week low | 69 |
| P/B ratio | 1.57 |
| Debt to equity | 1.01 |
| ROE (%) | 14.57% |
| Book value | ₹54.16 |
| Face value | ₹10 |
52 week high
52 week low
P/B ratio
Debt
Equity
ROE (%)
| Metric | Value |
|---|---|
| 52 week high | 99.3 |
| 52 week low | 69 |
| P/B ratio | 1.57 |
| Debt | 50.2% of capital |
| Equity | 49.8% of capital |
| ROE (%) | 14.57% |
Registry
| Metric | Value |
|---|---|
| PAN number | AACCM0306Q |
| ISIN number | INE182F01017 |
| CIN | U24231MH1993PLC150891 |
Figures in cr ·
Financials
| P&L Statement | 2023Latest | 2022 | 2021 |
|---|---|---|---|
| Revenue | 1341 | 1309 | 706 |
| EBITDA | 180 | 177 | -725 |
| OPM | 13.42 | 13.52 | -102.69 |
| PBT | 122 | 52 | 1869 |
| PAT | 122 | 52 | 1869 |
| EPS | 7.8 | 3.42 | 123.03 |
Shareholding Pattern
Arch Impex Private Limited
JM Financial Asset Reconstruction Company Limited
Arch Pharmachem Limited
Others
| Holder | Percentage |
|---|---|
| Arch Impex Private Limited | 25.24% |
| JM Financial Asset Reconstruction Company Limited | 35.41% |
| Arch Pharmachem Limited | 13.54% |
| Others | 25.81% |
Frequently asked questions
Common questions on Arch Pharmalabs Limited Unlisted Share—tap a row to read the answer.
Q.1How can I buy Arch Pharmalabs Limited Unlisted Shares?
If you're planning to buy Arch Pharmalabs Limited unlisted shares, you'll generally need an active Demat account, PAN, bank account, and completed KYC. Begin by checking the latest share price and availability in the unlisted market.
Once the price and quantity are finalized, you can complete the payment as agreed. After the settlement process is completed, the shares are transferred to your Demat account. Before investing, it's advisable to evaluate the company's business model, financial performance, product portfolio, and long-term growth prospects.
Q.2How can I sell Arch Pharmalabs Limited Unlisted Shares?
If you already own Arch Pharmalabs Limited unlisted shares and wish to sell them, you can first check the current buying price and market demand.
After agreeing on the transaction details with a buyer, the shares are transferred from your Demat account through the standard settlement process. Once the transfer is completed, the payment is released as agreed. Since these are unlisted shares, liquidity and pricing depend on buyer availability and market demand.
Q.3What is the lock-in period for Arch Pharmalabs Limited Unlisted Shares?
Generally, there is no standard lock-in period for unlisted shares unless specific restrictions apply to a particular allotment or transaction.
If Arch Pharmalabs Limited launches an IPO in the future, shares purchased before the IPO may become subject to a lock-in period under the SEBI regulations applicable at that time. Investors should review the latest regulatory guidelines before investing.
Q.4How is DIS used to sell Arch Pharmalabs Limited Unlisted Shares?
A Delivery Instruction Slip (DIS) is used to authorize the transfer of shares from your Demat account to the buyer's Demat account.
The seller fills in details such as the ISIN, number of shares, and the buyer's Demat account information before submitting the DIS to the Depository Participant (DP). Many DPs also provide an electronic eDIS facility, making the transfer process faster and more convenient.
Q.5What is the minimum investment required to buy Arch Pharmalabs Limited Unlisted Shares?
The minimum investment depends on the current Arch Pharmalabs share price and the minimum quantity available for purchase.
Since prices and availability change over time, there is usually no fixed minimum investment amount. It's advisable to check the latest market price and available quantity before making an investment decision.
Q.6Is buying Arch Pharmalabs Limited Unlisted Shares legal in India?
Yes. Buying and selling unlisted shares is generally legal in India, provided the transaction is carried out in accordance with applicable laws and regulations.
Investors should complete the required KYC formalities, use valid Demat and bank accounts, and maintain proper transaction records. Conducting thorough due diligence before investing is also recommended.
Q.7How are short-term capital gains on Arch Pharmalabs Limited Unlisted Shares taxed?
If you sell your shares within the holding period classified as short-term under the prevailing Income Tax rules, the profit earned may be treated as Short-Term Capital Gain (STCG).
The applicable tax depends on the tax laws in force at the time of sale and your individual tax circumstances. Since tax regulations may change over time, consulting a qualified tax advisor is recommended.
Q.8How are long-term capital gains on Arch Pharmalabs Limited Unlisted Shares taxed?
If the shares are held for the period required to qualify as a long-term capital asset before being sold, the gains may be treated as Long-Term Capital Gain (LTCG).
The applicable tax treatment depends on the prevailing Income Tax provisions at the time of sale. Investors should maintain proper records of the purchase date, acquisition cost, and sale value to ensure accurate tax calculation and smooth tax filing.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

NSE IPO 2026: Dates, Allotment & Listing Details
The much-awaited NSE IPO is set to make a major market debut in September 2026. As per the announced schedule, the IPO will open on 21 September and close on 23 September 2026, followed by share allotment on 24 September and listing on 28 September 2026. With strong investor interest and NSE’s position as one of India’s leading market institutions, the IPO is expected to attract significant attention. Here’s a quick look at the NSE IPO 2026 timeline and important dates investors should know.

Upcoming IPOs in 2026: NSE, Rentomojo, Manipal & Pranav Guide
Four major 2026 IPOs: NSE, Manipal Payment, Rentomojo, Pranav Constructions. For pre-IPO investors, these mark critical transitions from private to public valuations. Conduct due diligence before investing.

Purple Style Labs: From Unlisted Shares to IPO - A Price Journey Worth Noticing
Purple Style Labs is making headlines as it moves from the unlisted market towards its IPO. With its unlisted shares trading around ₹500–₹525 and an IPO price band of ₹546–₹575, the price journey offers an interesting look at how private-market and IPO valuations can differ.

Muthoot FinCorp Unlisted Shares: Q1FY27 Profit Surges to ₹705 Cr | Fundamentals & IPO
Muthoot FinCorp's Q1FY27 profit surged to ₹705.48 crore as the company moves toward a proposed ₹3,000-crore IPO. Here's a look at its financial performance, valuation metrics, asset quality and key fundamentals.

From Debt to Debt-Free: How API Holdings Used Thyrocare to Reshape Its Balance Sheet
API Holdings has repaid ₹1,050 crore of debt by monetising a 9.90% stake in Thyrocare while retaining 51.02% control. Here's how the move reshapes its balance sheet and what it means going forward.

Pre IPO Shares in India: Price, How to Buy & Complete Guide
Learn what Pre IPO Shares are, how their prices are determined, how to buy them in India, and what investors should check before investing in unlisted companies.
